Look at this........i already make a entry

103
🧪 Fundamentals / Business Snapshot

What they do: Privi Speciality Chemicals is a major Indian manufacturer, exporter, and supplier of aroma & fragrance chemicals. Their capability includes many complex operations (distillation, condensation, hydrogenation etc).

Recent financials:
  • In FY25, revenue rose ~ 19.9 % to ~ ₹2,101.19 crore from ~ ₹1,752.23 Cr prev year.
  • Net profit nearly doubled—~ 97 % YoY to ~ ₹187.00 crore vs ~ ₹94.91 Cr the previous year.
  • In the most recent quarter (Q1 FY26), revenue ~ ₹567.80 Cr (up ~21.7 % YoY), net profit ~ ₹61.93 Cr (up ~97.4 % YoY).

Margins / Efficiency:
  • Operating / EBITDA margins have improved. For example, in recent quarters the OPM has been ~ 20-23 % in some reports.
  • ROE recently ~ 16.94 % vs its 5-yr average ~11.8 %.

Risks / concerns:
  • Some analysts / rating agencies see weaker long-term fundamentals: slow growth in net sales / operating profit over longer horizon, high debt/EBITDA in some reports.
  • Commodity input risk, foreign exchange risk (since exports are significant), margin pressure possible. (General for speciality chemicals)

Competitive / strategic positives:
  • Strong R&D, product mix improvements.
  • Export orientation gives access to global markets.



---

📊 Technical / Price Action View

Current trend & moving averages: According to ETMoney, the stock is hovering around key moving averages: the 20, 50, 100, 200-day EMAs/SMAs are giving “neutral” signals in many cases.

Momentum indicators:
  • RSI (14) ~ 48-50 area → neutral territory.
  • MACD in some sources is slightly negative or weak → indicates not strong momentum up currently.
  • Some resistance / support zones via pivot / classic technical tools: TipRanks shows pivot at ~ ₹2338, with resistance above and support below.

Recent behaviour:
  • The stock has hit 52-week highs in recent past, showing strong sentiment after good results.
  • However, price also seems to be consolidating / facing short-term corrections (QoQ revenue drops, expenses growth) in some quarters.


면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.